Cannabidiol is a chemical in the Cannabis sativa plant, also known as marijuana or hemp. Over 80 chemicals, known as cannabinoids, have been identified in the Cannabis sativa plant. While delta-9-tetrahydrocannabinol (THC) is the major active ingredient in marijuana, cannabidiol is also obtained from hemp, which contains only very small amounts of THC.
Another reported side effect of CBD administration is an unpleasant dry sensation in the mouth. This effect seems to be caused by the involvement of the endocannabinoid system in the inhibition of saliva secretion. A study published by Argentinian researchers back in 2006 showed that cannabinoid receptors (type 1 and 2) are present in the submandibular glands which are responsible for producing saliva.
As more and more states legalize the use of marijuana, a product known as CBD oil has surged in popularity. A chemical compound found in the cannabis plant, CBD, or cannabidiol, is non-intoxicating and does not cause the noticeable euphoric effects associated with tetrahydrocannabinol (or THC, another marijuana compound). Products marketed as CBD oil may contain THC.
In short, the results of the survey (which were published in the Journal of Pain Research) showed that roughly 42% and 46% (respectively) of participants claimed they were able to use cannabis in place of traditional medical to effectively treat their specific medical ailment. So if you’re wondering how to know if you need CBD for pain, remember that you’re certainly not alone.
CBD oil has been explored as a potential treatment for schizophrenia. Human trials are a little more advanced when it comes to using CBD oil to treat psychological problems. A 2012 study by a team of nine researchers in Germany, Italy, and the United States investigated the effects of cannabidiol on brain activity in patients with a diagnosis of schizophrenia (3).
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).